3D Bioprinting

choice of materials

The and cell source is essential and specific to the tissue form and function.

Charles W Hull

3D printing was first described in 1986 by .

choice of materials

The and cell source is essential and specific to the tissue form and function.

Charles W Hull

3D printing was first described in 1986 by .

Japanese conglomerate

Terumo, a(n) , has commercialized the Heart Sheet for treatment of heart failure in Japan.

3D

bioprinting has already been used for the generation and transplantation of several tissues, including multilayered skin, bone, vascular grafts, tracheal splints, heart tissue and cartilaginous structures.

3D printing

, is driving major innovations in many areas, such as engineering, manufacturing, art, education and medicine.

Heart Sheet

To develop , muscle tissue is harvested from the patients leg and cultured in vitro.

Tel Aviv University

Unveiled the first 3D bioprinted heart with human tissue

Terumo

a Japanese conglomerate

Medical Printing

Biocompatible materials, cells and supporting components into complex 3D functional living tissues

Medical Usage

Used for the generation and transplantation of several tissues, including multilayered skin, bone, vascular grafts, tracheal splints, heart tissue and cartilaginous structures

Sterolithography

Thin layers of a material that can be cured with ultraviolet light were sequentially printed in layers to form a solid 3D structure

The choice of materials and cell source

----------------------- essential and specific to the tissue form and function

Transplant

Is a medical procedure in which an organ is removed from one body and placed in the body of a recipient